{"filing":{"accession_number":"0001683168-26-006344","cik":"0000882291","ticker":"AEMD","company_name":"AETHLON MEDICAL INC","form":"8-K","filing_date":"2026-08-13","report_date":"2026-08-13","primary_document":"aethlon_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316826006344/aethlon_8k.htm"},"events":[{"id":27628,"run_id":25193,"accession_number":"0001683168-26-006344","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses quarterly financial results for the period ended June 30, 2026, including a press release issued on August 13, 2026 (Exhibit 99.1) that reports Q1 fiscal 2027 results with consolidated balance sheets and statements of operations. The Item 2.02 explicitly incorporates Item 7.01 (Regulation FD Disclosure) which contains the earnings announcement, making this a standard earnings release disclosure with financial statements and operational highlights.","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-08-13","form":"8-K","submitted_at":null,"items":[{"id":29219,"accession_number":"0001683168-26-006344","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses quarterly financial results for the period ended June 30, 2026, including a press release issued on August 13, 2026 (Exhibit 99.1) that reports Q1 fiscal 2027 results with consolidated balance sheets and statements of operations. The Item 2.02 explicitly incorporates Item 7.01 (Regulation FD Disclosure) which contains the earnings announcement, making this a standard earnings release disclosure with financial statements and operational highlights.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T03:04:36.543091+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29219,"accession_number":"0001683168-26-006344","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses quarterly financial results for the period ended June 30, 2026, including a press release issued on August 13, 2026 (Exhibit 99.1) that reports Q1 fiscal 2027 results with consolidated balance sheets and statements of operations. The Item 2.02 explicitly incorporates Item 7.01 (Regulation FD Disclosure) which contains the earnings announcement, making this a standard earnings release disclosure with financial statements and operational highlights.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T03:04:36.543091+00:00","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-08-13"}]}